NASDAQ (usa) |
![]() |
6715.56 | -12.11 | -0.18% |
FTSE 100 (london) |
![]() |
7487.96 | -5.12 | -0.07% |
DAX (german) |
![]() |
13465.51 | 235.94 | 1.78% |
NIKKEI 225 (japan) |
![]() |
22420.08 | 408.47 | 1.86% |
Hang - Seng (hong kong) |
![]() |
28594.06 | 348.52 | 1.23% |
NIFTY - 50 (india) | ||||
Straits Times (singapore) |
![]() |
3391.61 | 17.53 | 0.52% |
KOSPI (korea) |
![]() |
2556.47 | 33.04 | 1.31% |
All Ordinaries (australia) |
![]() |
6005.30 | 28.90 | 0.48% |
BOVESPA (brazil) |
![]() |
74092.76 | -215.73 | -0.29% |
Valiant Laboratories Limited (NSE: VALIANTLAB)
VALIANTLAB Technical Analysis
1.5
As on 18th Jul 2025 VALIANTLAB INDIA- Price closed @ 102.79 and we RECOMMEND Sell for LONG-TERM with Stoploss of 113.40 & Buy for SHORT-TERM with Stoploss of 97.79 we also expect STOCK to react on Following IMPORTANT LEVELS. |
VALIANTLABINDIA- Price
Open | 106.85 | Change | Price | % |
High | 106.85 | 1 Day | -13.71 | -11.77 |
Low | 102.79 | 1 Week | -9.30 | -8.30 |
Close | 102.79 | 1 Month | -10.43 | -9.21 |
Volume | 97011 | 1 Year | -34.87 | -25.33 |
52 Week High 205.90 | 52 Week Low 76.58 |
NSE INDIA Most Active Stocks
IDEA | 7.72 | -0.52% |
JPPOWER | 22.86 | 0.57% |
GTLINFRA | 1.71 | -2.29% |
RTNPOWER | 15.17 | 0.53% |
NMDC | 71.44 | 2.70% |
YESBANK | 20.17 | 0.15% |
PCJEWELLER | 16.83 | -2.49% |
ALOKINDS | 20.82 | -5.54% |
GMDCLTD | 435.30 | 14.73% |
GATECH | 0.72 | -5.26% |
NSE INDIA Top Gainers Stocks
VIJIFIN | 3.81 | 19.81% |
GMDCLTD | 435.30 | 14.73% |
MANALIPETC | 79.25 | 14.66% |
BHAGYANGR | 106.41 | 13.23% |
VIMTALABS | 525.35 | 12.75% |
ORISSAMINE | 5228.10 | 10.31% |
SINTERCOM | 141.22 | 10.16% |
VERTOZ | 101.98 | 10.00% |
CUPID | 146.77 | 9.81% |
CAPITALSFB | 309.10 | 8.53% |
NSE INDIA Top Losers Stocks
VALIANTLAB Daily Charts |
VALIANTLAB Intraday Charts |
Whats New @ Bazaartrend |
VALIANTLAB Free Analysis |
|
VALIANTLAB Important Levels Intraday
RESISTANCE | 110.61 |
RESISTANCE | 108.10 |
RESISTANCE | 106.55 |
RESISTANCE | 105.00 |
SUPPORT | 100.58 |
SUPPORT | 99.03 |
SUPPORT | 97.48 |
SUPPORT | 94.97 |
VALIANTLAB Target July 2025
4th UP Target | 143.3 |
3rd UP Target | 127.97 |
2nd UP Target | 118.5 |
1st UP Target | 109.03 |
1st DOWN Target | 81.99 |
2nd DOWN Target | 72.52 |
3rd DOWN Target | 63.05 |
4th DOWN Target | 47.72 |
VALIANTLAB Weekly Target
4th UP Target | 135.02 |
3rd UP Target | 127.67 |
2nd UP Target | 123.12 |
1st UP Target | 118.58 |
1st DOWN Target | 105.60 |
2nd DOWN Target | 101.06 |
3rd DOWN Target | 96.51 |
4th DOWN Target | 89.16 |
VALIANTLAB Target2025
4th UP Target | 332.25 |
3rd UP Target | 261.34 |
2nd UP Target | 217.5 |
1st UP Target | 173.67 |
1st DOWN Target | 48.59 |
2nd DOWN Target | 4.76 |
3rd DOWN Target | -39.08 |
4th DOWN Target | -109.99 |
Valiant Laboratories Limited ( NSE INDIA Symbol : VALIANTLAB )
Sector : N/A And Other Stocks in Same Sector
Sector : N/A And Other Stocks in Same Sector
VALIANTLAB Synopsis Technicals View
50 Day EMA |
N/A (Short Term) |
N/A | |
100 Day EMA | N/A (Mid Term) | N/A | |
200 Day EMA | N/A (Long Term) | N/A | |
MACD (12 26 9) | N/A | N/A | |
RSI (14) | N/A | N/A | |
MFI (14) | N/A | N/A | |
CCI (20) | N/A | N/A | |
WILLIAM %R (14) | N/A | N/A | |
ADX (14) | N/A | N/A | |
PSAR | N/A | N/A | |
10 Day Avg Volume | N/A |
VALIANTLAB Other Details
Segment | EQ | |
Market Capital | 0.00 | |
Sector | ||
Industry | ||
Offical website | > echo $website ; ?> |
VALIANTLAB Address
![]() |
VALIANTLAB Latest News
VALIANTLAB Business Profile
N/A
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service